Understanding and Targeting Apoptotic Pathways in Ovarian Cancer

被引：26
|
作者：
Al-Alem, Linah F. [1 ,2 ]
Baker, Andrew T. [1 ,2 ]
Pandya, Unnati M. [1 ,2 ]
Eisenhauer, Eric L. [1 ,2 ,3 ]
Rueda, Bo R. [1 ,2 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Dept Obstet & Gynecol, Boston, MA 02114 USA
[2] Harvard Med Sch, Obstet & Gynecol, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Gynecol & Oncol Div, Boston, MA 02114 USA
来源：
CANCERS | 2019年 / 11卷 / 11期
关键词：
apoptosis; ovarian cancer; chemoresistance; glycosylation; miRNA; clinical trials; X-LINKED INHIBITOR; CELL-DEATH; CISPLATIN RESISTANCE; DOWN-REGULATION; PROMOTES APOPTOSIS; MUTANT P53; PROTEIN GLYCOSYLATION; MOLECULAR-MECHANISMS; REGULATES APOPTOSIS; GLUCOSE-METABOLISM;
D O I：
10.3390/cancers11111631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from external forces such as blunt trauma to programmed processes such as apoptosis, autophagy, or necroptosis. This review focuses on apoptosis, which is one form of programmed cell death. It highlights the multiple signaling pathways that promote or inhibit apoptosis and reviews current clinical therapies that target apoptotic pathways in ovarian cancer.
引用
收藏
页数：27
相关论文
共 50 条
  • [1] Targeting apoptotic pathways for cancer therapy
    Tian, Xiaobing
    Srinivasan, Praveen R.
    Tajiknia, Vida
    Uruchurtu, Ashley F. Sanchez Sevilla
    Seyhan, Attila A.
    Carneiro, Benedito A.
    De La Cruz, Arielle
    Pinho-Schwermann, Maximilian
    George, Andrew
    Zhao, Shuai
    Strandberg, Jillian
    Di Cristofano, Francesca
    Zhang, Shengliang
    Zhou, Lanlan
    Raufi, Alexander G.
    Navaraj, Arunasalam
    Zhang, Yiqun
    Verovkina, Nataliia
    Ghandali, Maryam
    Ryspayeva, Dinara
    El-Deiry, Wafik S.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (14):
  • [2] Targeting apoptotic pathways in cancer cells
    Denicourt, C
    Dowdy, SF
    SCIENCE, 2004, 305 (5689) : 1411 - 1413
  • [3] Therapeutic targeting of apoptotic pathways in cancer
    Meiler, Johannes
    Schuler, Martin
    CURRENT DRUG TARGETS, 2006, 7 (10) : 1361 - 1369
  • [4] Targeting apoptotic and autophagic pathways for cancer therapeutics
    Liu, Jun-jie
    Lin, Mou
    Yu, Jia-ying
    Liu, Bo
    Bao, Jin-ku
    CANCER LETTERS, 2011, 300 (02) : 105 - 114
  • [5] Targeting signaling pathways in ovarian cancer
    Reibenwein, J.
    Krainer, M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (03) : 353 - 365
  • [6] Targeting of apoptotic pathways in cancer cells by zoledronic acid
    Mitrofan-Oprea, Laura
    Jauhiainen, Marjo
    Pelkonen, Jukka
    Monkkonen, Jukka
    BONE, 2008, 42 : S102 - S102
  • [7] Targeting Apoptotic Signaling Pathways in Human Lung Cancer
    Han, S. W.
    Roman, J.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (06) : 566 - 574
  • [8] Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
    Jan, Rehmat
    Chaudhry, Gul-e-Saba
    ADVANCED PHARMACEUTICAL BULLETIN, 2019, 9 (02) : 205 - 218
  • [9] Targeting Signaling Pathways in Epithelial Ovarian Cancer
    Smolle, Elisabeth
    Taucher, Valentin
    Pichler, Martin
    Petru, Edgar
    Lax, Sigurd
    Haybaeck, Johannes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05): : 9536 - 9555
  • [10] Therapeutic Targeting of Apoptotic Pathways: Novel Aspects in Pancreatic Cancer
    Neesse, A.
    Gress, T. M.
    Michl, P.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (11) : 2273 - 2282
12345